Caricamento...
A score to predict short-term risk of COPD exacerbations (SCOPEX)
BACKGROUND: There is no clinically useful score to predict chronic obstructive pulmonary disease (COPD) exacerbations. We aimed to derive this by analyzing data from three existing COPD clinical trials of budesonide/formoterol, formoterol, or placebo in patients with moderate-to-very-severe COPD and...
Salvato in:
| Pubblicato in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4315304/ https://ncbi.nlm.nih.gov/pubmed/25670896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S69589 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|